🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-525025-12-00
Withdrawn Phase I

A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people

2025-525025-12-00 · tracked via the Priya Life Science EU tracker
Sponsor
Pharmacosmos A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Hemic and Lymphatic Diseases
Decision date
07/04/2026
Enrollment target
18
Sites
Netherlands

Condition studied

Iron overload from thalassemia, transfusion-dependent myelodysplastic syndromea and haemolysis

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-525025-12-00 on CTIS ↗ ← All trials in the EU